| Literature DB >> 29731169 |
Mohammad Mohseni Sajadi1, Amir Dashti2, Zahra Rikhtegaran Tehrani3, William D Tolbert2, Michael S Seaman4, Xin Ouyang2, Neelakshi Gohain2, Marzena Pazgier2, Dongkyoon Kim5, Guy Cavet5, Jean Yared6, Robert R Redfield2, George K Lewis2, Anthony L DeVico2.
Abstract
Anti-HIV-1 envelope broadly neutralizing monoclonal antibodies (bNAbs) isolated from memory B cells may not fully represent HIV-1-neutralizing profiles measured in plasma. Accordingly, we characterized near-pan-neutralizing antibodies extracted directly from the plasma of two "elite neutralizers." Circulating anti-gp120 polyclonal antibodies were deconvoluted using proteomics to guide lineage analysis of bone marrow plasma cells. In both subjects, a single lineage of anti-CD4-binding site (CD4bs) antibodies explained the plasma-neutralizing activity. Importantly, members of these lineages potently neutralized 89%-100% of a multi-tier 117 pseudovirus panel, closely matching the specificity and breadth of the circulating antibodies. X-ray crystallographic analysis of one monoclonal, N49P7, suggested a unique ability to bypass the CD4bs Phe43 cavity, while reaching deep into highly conserved residues of Layer 3 of the gp120 inner domain, likely explaining its extreme potency and breadth. Further direct analyses of plasma anti-HIV-1 bNAbs should provide new insights for developing antibody-based antiviral agents and vaccines.Entities:
Keywords: HIV-1; antibody; broadly neutralizing antibody; humoral immunity; pan-neutralization; repertoire
Mesh:
Substances:
Year: 2018 PMID: 29731169 PMCID: PMC6003858 DOI: 10.1016/j.cell.2018.03.061
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582